Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. (Q40094198)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 August 2007

Language	Label	Description	Also known as
English	Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.	scientific article published on 13 August 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Scott H Kaufmann

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

12

object named as

Alex A Adjei

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

9

object named as

Shaji K Kumar

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Xue Wei Meng

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sun-Hee Lee

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Haiming Dai

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

David Loegering

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Chunrong Yu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Karen Flatten

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Paula Schneider

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nga T Dai

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

B Douglas Smith

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Judith E Karp

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

0 references

publication date

13 August 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

number of pages

16

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

282

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

41

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

29831-29846

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698840%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nature's TRAIL--on a path to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Targeting death receptors in cancer with Apo2L/TRAIL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

On the TRAIL of a new therapy for leukemia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Apoptosis in the treatment of cancer: a promise kept?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

TRAIL and apoptosis induction by TNF-family death receptors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Death receptor-induced cell killing

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Mammalian mitochondrial IAP binding proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Increased expression of Mcl-1 is responsible for the blockage of TRAIL-induced apoptosis mediated by EGF/ErbB1 signaling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

JNK/SAPK activity contributes to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Inhibition of human caspases by peptide-based and macromolecular inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

The role of apoptosis in cancer development and treatment response

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Life in the balance: how BH3-only proteins induce apoptosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

The saintly side of Smac/DIABLO: giving anticancer drug-induced apoptosis a boost

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Reutilization of Immunoblots after Chemiluminescent Detection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

A subset of non-histone nuclear proteins reversibly stabilized by the sulfhydryl cross-linking reagent tetrathionate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706110200

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40094198&oldid=1769772237"